Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation.
Wijnenga MMJ, Maas SLN, van Dis V, Tesileanu CMS, Kros JM, Dirven L, Hazelbag HM, Dubbink HJ, Vincent AJPE, French PJ, van den Bent MJ. Wijnenga MMJ, et al. Among authors: dirven l. Neurooncol Adv. 2023 Jun 21;5(1):vdad075. doi: 10.1093/noajnl/vdad075. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37441086 Free PMC article. No abstract available.
Corrigendum to: Palliative care and end-of-life care in adults with malignant brain tumors.
Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T. Koekkoek JAF, et al. Among authors: dirven l. Neuro Oncol. 2023 Jan 5;25(1):212. doi: 10.1093/neuonc/noac252. Neuro Oncol. 2023. PMID: 36610983 Free PMC article. No abstract available.
FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial.
Plaha P, Camp S, Cook J, McCulloch P, Voets N, Ma R, Taphoorn MJB, Dirven L, Grech-Sollars M, Watts C, Bulbeck H, Jenkinson MD, Williams M, Lim A, Dixon L, Price SJ, Ashkan K, Apostolopoulos V, Barber VS, Taylor A; FUTURE-GB collaborators; Nandi D. Plaha P, et al. Among authors: dirven l. BMJ Open. 2022 Nov 15;12(11):e064823. doi: 10.1136/bmjopen-2022-064823. BMJ Open. 2022. PMID: 36379652 Free PMC article. Clinical Trial.
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.
van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: dirven l. Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24. Ann Rheum Dis. 2011. PMID: 21515916 Clinical Trial.
Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.
Dirven L, Güler-Yüksel M, de Beus WM, Ronday HK, Speyer I, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF. Dirven L, et al. Arthritis Care Res (Hoboken). 2011 Dec;63(12):1691-9. doi: 10.1002/acr.20612. Arthritis Care Res (Hoboken). 2011. PMID: 21905248 Free article. Clinical Trial.
The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study.
van den Broek M, Dirven L, Klarenbeek NB, Molenaar TH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. van den Broek M, et al. Among authors: dirven l. Ann Rheum Dis. 2012 Feb;71(2):245-8. doi: 10.1136/annrheumdis-2011-200379. Epub 2011 Nov 21. Ann Rheum Dis. 2012. PMID: 22110122 Clinical Trial.
157 results